RAYMOND JAMES & ASSOCIATES - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 272 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2022$669,000
-23.2%
21,538
+1.6%
0.00%0.0%
Q1 2022$871,000
+18.2%
21,209
+25.1%
0.00%0.0%
Q4 2021$737,000
-22.5%
16,951
-10.7%
0.00%0.0%
Q3 2021$951,000
-14.5%
18,987
+7.5%
0.00%0.0%
Q2 2021$1,112,000
-61.8%
17,656
-43.6%
0.00%
-66.7%
Q1 2021$2,908,000
+60.6%
31,297
+54.8%
0.00%
+50.0%
Q4 2020$1,811,000
-8.9%
20,216
+5.1%
0.00%0.0%
Q3 2020$1,988,000
+48.0%
19,236
+13.2%
0.00%0.0%
Q2 2020$1,343,000
+88.1%
16,989
+37.7%
0.00%
+100.0%
Q1 2020$714,000
+189.1%
12,335
+161.4%
0.00%
Q3 2019$247,000
-46.2%
4,718
-48.0%
0.00%
-100.0%
Q1 2019$459,000
-30.6%
9,081
-18.6%
0.00%0.0%
Q4 2018$661,000
-6.5%
11,155
+3.9%
0.00%0.0%
Q3 2018$707,000
+34.4%
10,739
+3.0%
0.00%0.0%
Q2 2018$526,000
-7.4%
10,422
-3.5%
0.00%0.0%
Q1 2018$568,000
+59.6%
10,796
+40.9%
0.00%0.0%
Q4 2017$356,000
+14.8%
7,6600.0%0.00%0.0%
Q3 2017$310,000
+13.1%
7,660
-5.1%
0.00%0.0%
Q2 2017$274,000
+31.7%
8,074
+12.8%
0.00%
Q1 2017$208,000
-10.0%
7,159
+1.9%
0.00%
-100.0%
Q4 2016$231,000
+11.1%
7,024
+6.4%
0.00%0.0%
Q3 2016$208,000
-12.6%
6,600
-21.9%
0.00%0.0%
Q2 2016$238,000
-22.2%
8,456
+0.4%
0.00%0.0%
Q1 2016$306,0008,4200.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Values First Advisors, Inc. 152,699$519,1780.34%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 299,187$1,017,0000.22%
Hilltop Holdings Inc. 235,019$799,0640.09%
AIMZ Investment Advisors, LLC 51,372$174,6650.08%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 868,605$2,953,2570.07%
PALISADE CAPITAL MANAGEMENT, LP 509,325$1,731,7050.05%
SHERBROOKE PARK ADVISERS LLC 41,417$140,8180.04%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2,428,490$8,256,8660.03%
Y-Intercept (Hong Kong) Ltd 75,362$256,2310.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,246,020$4,236,4680.02%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders